This is a prospective, multi-center, randomized, controlled, patient* and evaluator-blinded study comparing treatment with the CardiAMP cell therapy to a sham control treatment. A roll-in phase with a maximum of 10 subjects may occur.
- Investigator
- R. David Anderson
- Ages
- 21 Years - 90 Years
- Sexes
- All